Cooperative effect of cell-cycle regulators expression on bladder cancer development and biologic aggressiveness
Open Access
- 1 April 2007
- journal article
- research article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 20 (4), 445-459
- https://doi.org/10.1038/modpathol.3800757
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Outcomes of Radical Cystectomy for Transitional Cell Carcinoma of the Bladder: A Contemporary Series From the Bladder Cancer Research ConsortiumJournal of Urology, 2006
- p53, p21, pRB, and p16 Expression Predict Clinical Outcome in Cystectomy With Bladder CancerJournal of Clinical Oncology, 2004
- Assessment of HER-2/neu Status in Breast CancerAmerican Journal of Clinical Pathology, 2001
- Loss of Cell Cycle Regulators p27Kip1 and Cyclin E in Transitional Cell Carcinoma of the Bladder Correlates with Tumor Grade and Patient SurvivalThe American Journal of Pathology, 1999
- Level of retinoblastoma protein expression correlates with p16 (MTS-1/INK4A/CDKN2) status in bladder cancerOncogene, 1999
- p53 mutations in human bladder cancer: Genotypic versus phenotypic patternsInternational Journal of Cancer, 1994
- Nuclear Overexpression of p53 Protein in Transitional Cell Bladder Carcinoma: A Marker for Disease ProgressionJNCI Journal of the National Cancer Institute, 1993
- Altered Expression of the Retinoblastoma Gene Product: Prognostic Indicator in Bladder CancerJNCI Journal of the National Cancer Institute, 1992
- p53 Mutations in Human CancersScience, 1991
- The p53 tumour suppressor geneNature, 1991